로딩 중…
지수 로딩 중…
Verastem, Inc.
VSTM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$5.69-1.90%
2026-08-03
Financials
Valuation Metrics
Verastem, Inc.'s Market Cap is $500M. At end of 2025 it was $644M. Ranked #2805 of 3,112 in US market (top 90%), #1223 of 1,445 on NASDAQ (top 85%), #226 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 84%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $500M | US#2,805/3,112 Sec#226/269 |
| Revenue | $50M | US#2,864/3,112 Sec#157/269 |
| Net Income | $-194M | US—/3,112 Sec—/269 |
| Total Assets | $228M | US#2,958/3,112 Sec#241/269 |
| Net Assets | $82M | US#2,898/3,112 Sec#233/269 |
| Value | ||
| P/B | 6.11x | US#2,323/3,112 Sec#159/269 |
| P/S | 10.08x | US#2,656/3,112 Sec#121/269 |
| FCF Yield | -30.46% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROA | -85.14% | US#3,036/3,112 Sec#258/269 |
| Op. Margin | -344.56% | US#2,883/3,112 Sec#155/269 |
| Revenue Growth | 209.14% | US#70/3,112 Sec#22/269 |
| Financial Health | ||
| Debt Ratio | 178.57% | US#1,676/3,112 Sec#196/269 |
| Total Debt | $85M | US#2,423/3,112 Sec#124/269 |
| FCF | $-152M | US#2,685/3,112 Sec#192/269 |
| Cash | $166M | US#1,867/3,112 Sec#135/269 |
| Current Ratio | 3.04x | US#798/3,112 Sec#194/269 |
| Performance | ||
| 1Y Return | -6.41% | US#2,224/3,112 Sec#203/269 |
| 1M Return | 26.44% | US#68/3,112 Sec#5/269 |
| From 52W High | -49.42% | US#2,769/3,112 Sec#217/269 |
| 1Y MDD | -67.97% | US#2,888/3,112 Sec#243/269 |
| Trading | ||
| Volume | 1,030,477 shares | US#1,441/3,112 Sec#142/269 |
| Trading Value | $6M | US#2,604/3,112 Sec#213/269 |
| Per Share | ||
| EPS | $-2.51 | US—/3,112 Sec—/269 |
| BPS | $0.69 | US#2,661/3,112 Sec#212/269 |